Technology
Health
Biotechnology
aTyr Pharma
$3.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.12 (4.27%) Today
+$0.08 (2.76%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell aTyr Pharma and other stocks, options, ETFs, and crypto commission-free!
About LIFE
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. Read More The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Employees
42
Headquarters
San Diego, California
Founded
2005
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
49.85K
High Today
$3.09
Low Today
$2.76
Open Price
$2.80
Volume
82.37K
52 Week High
$12.33
52 Week Low
$2.76
Collections
Technology
Health
Biotechnology
Therapy
2015 IPO
US
North America
LIFE Earnings
-$2.74
-$1.89
-$1.03
-$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$2.74 per share
Actual
-$1.80 per share